News
LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment
Real-World Findings Support Long-Term Benefits of Continuous Treatment with LEQEMBI and Provide Important Insights into Treatment Experience Outside of a Clinical Trial Setting TOKYO and CAMBRIDGE, Ma
Blackbaud: Focus On New Investment And Recent Corporate Updates
Blackbaud: Focus On New Investment And Recent Corporate Updates
Fed Chair Kevin Warsh says central bank has 'no tolerance' for elevated inflation
Fed Chair Kevin Warsh told lawmakers the central bank won't tolerate persistently elevated inflation and will take the steps needed to preserve price stability.
SRAD EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Sportradar (SRAD) Investors of Securities Class Action Lawsuit Deadline on July 17, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Sportradar To Contact Him Directly To Discuss Their Options If you purchased or acqui
BRCB Shareholder Alert: Black Rock Coffee Bar, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt
Important Information Regarding Section 20(a) Individual Liability Claims Against Black Rock Coffee Bar's CEO and CFO for Alleged Store Cannibalization Concealment That Cost Shareholders $3.32 Per Sha
ZTS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Zoetis Inc. Securities Lawsuit - Contact SueWallSt
Zoetis CEO Kristin Peck and CFO Wetteny Joseph Face Personal Liability for Allegedly Certifying Misleading Statements About Companion Animal Product Performance While Safety Concerns and Competitive L
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 3, 2026 in GeneDx Holdings Corp. Lawsuit - WGS
Key Dates and Disclosure Events GeneDx Shareholders Need to Know: From $51 Million Acquisition Promise to $31.2 Million Write-Off in Just 12 Months Key Dates and Disclosure Events GeneDx Shareholders
Snapchat: The Profit Era May Soon Begin
Snapchat remains deeply undervalued despite tepid growth and sector pessimism; I reiterate a "Strong Buy" rating. SNAP's revenue grew 12% YoY, driven by ARPU increases, but North America DAUs declined
Chamath Palihapitiya says soaring AI token spend will hit companies' earnings
Tech investor Chamath Palihapitiya said AI usage could negatively impact some companies' earnings. "CEOs and the CFOs, in my opinion, probably have no idea how much tokenmaxxing is going on inside of
IBM Stock Plunges Over 20% After Weak Q2 Results; CEO Admits Tech Giant ‘Faltered'
IBM stock is getting hammered and dragging other software stocks down with it after the tech giant warned clients are pulling back spending.
These 3 Water ETFs Could be Quiet Winners From Infrastructure Spending
Data centers receive sharp criticism for their high water usage, but the impact on the broader water industry and for investors is also about infrastructure bottlenecks, regulation, and emerging techn
Watch the Kaspi Event: Mikheil Lomtadze Unveils Kasper
Kaspi.kz presents its vision to bring a personal AI assistant to every customer Kaspi.kz presents its vision to bring a personal AI assistant to every customer
CVLT EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Commvault (CVLT) Investors of Securities Class Action Lawsuit Deadline on July 17, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Commvault To Contact Him Directly To Discuss Their Options If you purchased or acquir
GTM Shareholder Alert: August 24, 2026 Lead Plaintiff Deadline in ZoomInfo Technologies, Inc. Securities Class Action - Contact SueWallSt
Notice to Pension Funds, Asset Managers, and Fiduciaries Holding ZoomInfo Technologies Shares During the Class Period: Evaluate Lead Plaintiff Opportunities Following Alleged $1.98 Per-Share Loss Noti
Levi & Korsinsky Notifies Investors of a Pending Investigation Into Securities Claims Involving Ionis Pharmaceuticals (IONS)
Ionis Pharmaceuticals (NASDAQ: IONS) investors absorbed a >20% share decline after the Phase-3 CARDIO-TTRansform trial missed its primary endpoint. Levi & Korsinsky is investigating potential securiti
AppLovin: Amazing Buying Opportunity On The Recent Selling Frenzy
AppLovin (APP) remains a strong buy as it navigates a recent selling frenzy as it launches its self-serve ad engine into general availability. APP's growth hinges on expanding beyond gaming into the m
Earnings season plays: Profit expectations are growing for these stocks while their valuations get cheaper
Investors can find opportunities in stocks where declining share prices are pushing valuations below their historical average.
PODD Shareholder Alert: Insulet Corporation Securities Class Action Lawsuit - Investors Should Contact SueWallSt
Insulet's CEO and CFO Named as Individual Defendants Under Section 20(a) for Alleged Cumulative Losses Stemming from Defective Omnipod Manufacturing Controls Insulet's CEO and CFO Named as Individual
Longleaf Small-Cap Fund Q2 2026 Portfolio Review
New York real estate companies Alexander's and Empire State Realty Trust both contributed in the quarter. Alcoholic beverage company Boston Beer was a detractor for the quarter as the market continues
FSLR Shareholder Alert: August 24, 2026 Lead Plaintiff Deadline in First Solar, Inc. Securities Class Action - Contact SueWallSt
Notice to Pension Funds, Asset Managers, and Fiduciaries Holding First Solar Positions: Alleged Tariff Misrepresentations and Production Facility Underutilization May Have Inflated FSLR Portfolio Valu
